Company profile for Zambon Group SpA

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Established in Vicenza in 1906 and currently headquartered in Bresso, it operates on three continents - Europe, South America and Asia - with more than 2600 employees in 15 different countries and as at 31/12/2013, it had a consolidated revenue of € 563 Mio. Today, Zambon is a multicultural group which, in the patchy and constantly-changing scenario of the pharmaceutical industry, has managed to strengthen its competitive po...
Established in Vicenza in 1906 and currently headquartered in Bresso, it operates on three continents - Europe, South America and Asia - with more than 2600 employees in 15 different countries and as at 31/12/2013, it had a consolidated revenue of € 563 Mio. Today, Zambon is a multicultural group which, in the patchy and constantly-changing scenario of the pharmaceutical industry, has managed to strengthen its competitive position on the market. The need for increased flexibility and efficiency has encouraged Zambon to steer its organisational structure towards an increasingly integrated model.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Italy
Address
Address
Via Lillo del Duca, 10 - 20091 Bresso
Telephone
Telephone
+39 02 665241
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.zambon.com/en/media/press/2025-06-24-zambon-announces-approval-and-launch-china-intravenous-formulation

PRESS RELEASE
29 Jun 2025

https://www.businesswire.com/news/home/20250618274587/en/Zambon-Announces-Approval-and-Launch-in-China-of-the-Intravenous-Formulation-of-Fluimucil-N-acetylcysteine

BUSINESSWIRE
24 Jun 2025

https://www.zambon.com/en/media/press/2025-02-26-massimo-grandi-joins-zambon-chief-core-therapies-officer

PRESS RELEASE
26 Feb 2025

https://www.zambon.com/en/media/press/2024-09-24-zcube-zambon-research-venture-leads-c2-million-investment-round-canadian

PRESS RELEASE
24 Sep 2024

https://www.businesswire.com/news/home/20240923380059/en

BUSINESSWIRE
23 Sep 2024

https://www.zambon.com/sites/default/files/press/files/2024-09/open-accelerator-announces-5-startups-2024-program.pdf

PRESS RELEASE
23 Sep 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Zambon Group SpA and get a quotation

Zambon Group SpA is a supplier offers 7 products (APIs, Excipients or Intermediates).

Find a price of Diflunisal bulk offered by Zambon Group SpA

Find a price of Flurbiprofen bulk offered by Zambon Group SpA

Find a price of Iopamidol bulk offered by Zambon Group SpA

Find a price of Naproxen bulk offered by Zambon Group SpA

Find a price of Oxaprozin bulk offered by Zambon Group SpA

Find a price of Tasosartan bulk offered by Zambon Group SpA

Find a price of WAY-125,147 CRUDE bulk offered by Zambon Group SpA

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty